The Europe medical foods market size is expected to reach USD 7.31 billion by 2030, registering a CAGR of 2.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. The ever-increasing burden of chronic diseases and the growing geriatric population across Europe are primary reasons for the market to flourish. In 2021, the oral route of administration accounted for the largest revenue share of 69.5%. Ease of use and high availability of medical foods in this form has contributed to the high revenue. The enteral route of administration is expected to register the fastest growth. This can be attributed to the growing geriatric population suffering from chronic diseases who are unable to consume food orally. The enteral route of administration seems to be the preferred way of administrating nutrients through medical foods to the specific needs of geriatric patients.
In the product type, the powder formulations held the largest revenue share in 2024. Owing to the vast product portfolios available in this formulation this segment has grown to a large extent. Powder formulations include nutrient mixes, protein shakes, and infant feeding formulas. The highest growth was registered by the liquid formulations due to the diversification of product portfolios of the key players in the medical foods industry. Cancer had the largest revenue share in 2024 in the applications segment. Nutritional deficiency in cancer patients is a major concern and can be managed through proper nutrient management via medical foods and is a major factor in its growth. The fastest-growing sub-segment is diabetic neuropathy, high prevalence, and has been a key driver for its fast growth.
The largest sales channel for 2024 was direct-to-consumer, owing to the emerged as a significant channel within the market, providing opportunities for manufacturers to engage directly with consumers and tailor their offerings to meet specific health needs.
Request a free sample copy or view report summary: Europe Medical Foods Market Report
Based on route of administration, the oral segment accounted for the largest revenue share of 76.1% in 2024 owing to high product type availability and ease of administration
In 2024, the powder formulation segment accounted for the largest revenue share of 35.2% owing to the majority product portfolio available in the market
By application, the cancer application segment dominated the market with the largest share of 11.7% in 2024
The institutional sales channel had the largest share, but the online sales channel is expected to grow at a steady rate owing to the preference of consumers and key player initiatives for sales through online channels
Grand View Research has segmented the Europe medical foods market on the basis of route of administration, product, application, module, sales channel, and region:
Europe Medical Foods Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
Oral
Enteral
Product Outlook (Revenue, USD Million, 2018 - 2030)
Powder
Pills
Liquid
Other
Europe Medical Foods Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Kidney Disease
Minimal Hepatic Encephalopathy
Chemotherapy Induced Diarrhea
Pathogen Related Infections
Diabetic Neuropathy
ADHD
Depression
Alzheimer's Disease
Nutritional Deficiency
Orphan Diseases
Tyrosinemia
Eosinophilic Esophagitis
FPIES
Phenylketonuria
MSUD
Homocystinuria
Others
Wound Healing
Chronic Diarrhea
Constipation Relief
Protein Booster
Dysphagia
Pain Management
Parkinson's Disease
Epilepsy
Other Cancer related treatments
Severe Protein Allergy
Cancer
Cachexia
Other (debilitating conditions, COPD, etc.)
Europe Medical Foods Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
Online Sales
Retail Sales
Institutional Sales
Europe Medical Foods Module Outlook (Revenue, USD Million, 2018 - 2030)
Amino Acid Module
Protein Module
Vitamin & Mineral Modules
Fatty Acid based Modules
Carbohydrate Modules
Fiber Modules
Ketogenic Modules
Peptide based Modules
Hypoallergic Modules
Others (Electrolyte Module, etc.)
Europe Medical Foods Regional Outlook (Revenue, USD Million, 2018 - 2030)
Europe
UK
Germany
Spain
France
Italy
Denmark
Sweden
Norway
Poland
Netherlands
Portugal
Slovakia
Finland
Czech Republic
Hungary
Belgium
List Of Key Players in the Europe Medical Foods Market
Danone
Nestlé
Abbott
Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
Primus Pharmaceuticals Inc.
Fresenius Kabi AG
Mead Johnson & Company, LLC
"The quality of research they have done for us has been excellent..."